fbpx Skip to main content

The ongoing COVID-19 pandemic has disrupted cancer screening and treatment programs. This study, published in Current Breast Cancer Reports, focuses on the pandemic’s effect on African American and Hispanic-Latina Americans with breast cancer.

The researchers found that African American and Hispanic-Latina patients have experienced disproportionately high morbidity and mortality from COVID-19. They stipulated that these findings are likely the result of a combination of socioeconomic factors, tumor biology, and genetic factors. They hypothesized that the factors that explain ongoing breast cancer disparities likely contribute to COVID-19 disparities.

The researchers concluded that a multifaceted public health approach is needed to mitigate the pandemic’s impact on patients with breast cancer, particularly African Americans and Hispanic-Latina Americans. A call to action is made to increase the number of diverse patients involved in COVID-19 treatment trials and vaccination efforts [1].

Source:

[1] Newman, L., Fejerman, L., Pal, T., Mema, E., McGinty, G., Cheng, A., Levy, M., Momoh, A., Troester, M., Schneider, B., McNeil, L., Davis, M., Babagbemi, K., & Hunt, K. (2021). Breast cancer disparities through the lens of the COVID-19 pandemic. Current Breast Cancer Reports, 13(3), 110–112. https://doi.org/10.1007/s12609-021-00419-x

Share this article
You May Also Like::  New Drug Elicits Positive Reaction for Treatment of Poor-Prognosis non-Hodgkin Lymphoma (NHL)